These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3546505)

  • 1. A sensitive method for testing the effect of immunoglobulin binding factor on Ig secretion by hybridoma B cells.
    Amigorena S; Moncuit J; Fridman WH; Teillaud JL
    J Immunol Methods; 1987 Feb; 97(1):57-64. PubMed ID: 3546505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hybridoma B-cell proliferation by immunoglobulin-binding factor.
    Teillaud JL; Mathiot C; Amigorena S; Brunati S; Moncuit J; Fridman WH
    Cancer Detect Prev; 1988; 12(1-6):115-23. PubMed ID: 3263193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin G-binding factors (IgG-BF) inhibit IgG secretion by, as well as proliferation of, hybridoma B cells.
    Teillaud JL; Amigorena S; Moncuit J; Sautès C; Fridman WH
    Immunol Lett; 1987 Nov; 16(2):139-44. PubMed ID: 3501404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of T cell hybridomas. III. Distinctions between two types of hapten-specific suppressor factors that affect plaque-forming cell responses.
    Sherr DH; Minami M; Okuda K; Dorf ME
    J Exp Med; 1983 Feb; 157(2):515-29. PubMed ID: 6185612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory effects of IgG-BF on hybridoma B cells. molecular characterization of variant cell lines.
    Brunati S; Miossec C; Mathiot C; Moncuit J; Amigorena S; Teillaud JL; Fridman WH
    Mol Immunol; 1988 Nov; 25(11):1133-42. PubMed ID: 2975759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro inhibition of tumor B cell growth by IgG-BF-producing Fc gamma RII+ T cell hybridoma and by immunoglobulin G-binding factors.
    Mathiot C; Amigorena S; Moncuit J; Sautès C; Fridman WH; Teillaud JL
    Immunol Res; 1992; 11(3-4):296-304. PubMed ID: 1287123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic, biologic and western blot analysis of human IgE-binding factor derived from a T cell hybridoma maintained in protein-free medium.
    Steele JK; Domingo R; Gomi H; Ishizaka K
    J Immunol; 1992 May; 148(9):2834-9. PubMed ID: 1573271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigen-induced proliferation and immunoglobulin A secretion by a human-human hybridoma.
    Splawski JB; Lipsky PE
    J Immunol; 1987 Sep; 139(5):1432-7. PubMed ID: 3040854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human suppressor factors constitutively produced by T-T cell hybridomas: functional and biochemical characterization.
    Kunicka JE; Calvelli TA; Fox FE; Steinberg J; Telerman A; Platsoucas C
    Hybridoma; 1989 Apr; 8(2):127-51. PubMed ID: 2785481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Software for the quantitative evaluation of in vitro monoclonal antibody production from ELISA data.
    Thibaut E; Amigorena S; Moncuit J; Fridman WH; Teillaud JL
    J Immunol Methods; 1987 Nov; 104(1-2):15-24. PubMed ID: 3680954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination.
    Proust JJ; Buchholz MA; Nordin AA
    J Immunol; 1985 Jan; 134(1):390-6. PubMed ID: 3871110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of IgE production in B hybridomas by IgE class-specific suppressor factor from T hybridomas.
    Suemura M; Ishizaka A; Kobatake S; Sugimura K; Maeda K; Nakanishi K; Kishimoto S; Yamamura Y; Kishimoto T
    J Immunol; 1983 Mar; 130(3):1056-60. PubMed ID: 6218197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical identification of glycosylation inhibiting factor.
    Katamura K; Iwata M; Mori A; Ishizaka K
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1903-7. PubMed ID: 2308951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of polyclonal human B cell activation by IgG binding factors: interference with the maturation of Ig-containing cells into Ig-secreting cells.
    Bich-Thuy LT; Banchereau J; Revillard JP
    Cell Immunol; 1984 Aug; 87(1):231-9. PubMed ID: 6204775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of DNA synthesis in secretion of immunoglobulin from murine B cells stimulated by T cell derived lymphokines.
    Simpson LG; Isakson PC
    J Immunol; 1986 Sep; 137(6):1797-802. PubMed ID: 3091690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isotype-specific immunoregulation. IgA-binding factors produced by Fc alpha receptor-positive T cell hybridomas regulate IgA responses.
    Kiyono H; Mosteller-Barnum LM; Pitts AM; Williamson SI; Michalek SM; McGhee JR
    J Exp Med; 1985 Apr; 161(4):731-47. PubMed ID: 2858511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a T-cell hybridoma producing a contrasuppressor factor for contact sensitivity.
    Friedman AM; Ptak W; Brewer E; Green DR; Reuter PA; Flood PM
    Immunology; 1990 Oct; 71(2):282-9. PubMed ID: 1699882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of an antigen-specific T cell subset that forms IgE-suppressive factor and IgG-suppressive factor on antigenic stimulation.
    Jardieu P; Uede T; Ishizaka K
    J Immunol; 1985 Aug; 135(2):922-9. PubMed ID: 2409160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency.
    Sherr E; Adelman DC; Saxon A; Gilly M; Wall R; Sidell N
    J Exp Med; 1988 Jul; 168(1):55-71. PubMed ID: 3294336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism controlling the genetic restrictions of an NP-specific suppressor factor that inhibits B cell responses.
    Hausman PB; Sherr DH; Dorf ME
    J Immunol; 1985 Aug; 135(2):915-21. PubMed ID: 2409159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.